ArticleCurrent microbiology2026
Isolation and Characterization of Variants of Quorum-Sensing Signal Molecules in Clinical Acinetobacter baumannii Isolates.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Acinetobacter baumannii is a multidrug-resistant nosocomial pathogen that poses a significant global health threat. Quorum sensing (QS), a communication system found in this bacterium, is pivotal in biofilm formation, virulence factor production, and its overall survival. This study aimed to detect, quantify, and characterize signaling molecules in representative high biofilm forming clinical isolates of A. baumannii, thereby advancing the chemical understanding of microbial communication signals in this clinically important pathogen and providing a foundation for future investigations into their biological roles. The clinical isolates were screened for QS-associated phenotypes, signal molecule production, and the compounds were extracted, purified, and identified by thin-layer chromatography, mass spectrometry, and nuclear magnetic resonance spectroscopy. The analyses identified the presence of the diketopiperazine cyclo (L-prolyl-L-valine) and the long-chain acyl-homoserine lactone C14:1-HSL in the examined A. baumannii isolates. Based on the available literature, these molecules have not been previously reported in A. baumannii. This variation highlights the diversity of signaling molecules associated with the clinical isolates examined. These findings expand current knowledge of the chemical profiles of signaling molecules produced by high-biofilm-forming A. baumannii isolates and provide a basis for future studies investigating their potential biological significance.
Indexed as
Identifiers
42645318What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.